GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,581,000 | -61.6% | 179,806 | -47.2% | 0.04% | -58.6% |
| Q2 2021 | $11,922,000 | -67.0% | 340,432 | -61.6% | 0.09% | -68.1% |
| Q1 2021 | $36,117,000 | +520.5% | 886,300 | +861.3% | 0.27% | +425.0% |
| Q2 2020 | $5,821,000 | +115.5% | 92,201 | +74.4% | 0.05% | +73.3% |
| Q1 2020 | $2,701,000 | -74.6% | 52,859 | -60.6% | 0.03% | -62.0% |
| Q4 2019 | $10,652,000 | +258.8% | 134,000 | +119.0% | 0.08% | +243.5% |
| Q3 2019 | $2,969,000 | -10.8% | 61,184 | -3.3% | 0.02% | -8.0% |
| Q2 2019 | $3,328,000 | -64.1% | 63,268 | -67.0% | 0.02% | -62.7% |
| Q1 2018 | $9,268,000 | – | 191,890 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |